Efficacy of combined varenicline and nicotine replacement therapy compared with varenicline or nicotine replacement therapy alone for smoking cessation: A systematic review and meta‐analysis
Addiction · 2026
DOI: 10.1111/add.70235 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Addiction, 2026. Verfasst von Xinmei Zhou und 18 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respir…. Hauptthemen laut MEDLINE: Varenicline, Smoking Cessation, Tobacco Use Cessation Devices, Smoking Cessation Agents. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine.
Abstract (Originalsprache)
Aims
To assess whether combining nicotine replacement therapy (NRT) with varenicline improves long‐term smoking cessation rates compared with varenicline or NRT alone.
Method
Systematic review and meta‐analysis of randomized controlled trials (RCTs) or quasi‐RCTs, conducted according to PRISMA guidelines. A comprehensive literature search of PubMed, MEDLINE, EMBASE, Web of Science and the Cochrane Central Register of Controlled Trials was conducted through June 2025. The primary outcome was smoking abstinence at the longest follow‐up (≥6 months). Secondary outcomes included adverse events (AEs) and serious adverse events (SAEs). Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using random‐effects meta‐analyses. The certainty of evidence was assessed using the GRADE approach. Risk of bias was assessed using the Cochrane RoB 2.0 tool. The protocol was pre‐registered in the PROSPERO (registration number CRD42024600510).
Results
Seven trials including 2631 participants met inclusion criteria. Compared with varenicline alone, combination therapy was associated with statistically significantly higher abstinence rates at the longest follow‐up (RR = 1.33, 95% CI = 1.04–1.69; 5 studies; I 2 = 51%). A sensitivity analysis including trials with ≥3 months of follow‐up yielded similar results (RR = 1.31, 95% CI = 1.06–1.62; 6 studies). However, when excluding the trial at high risk of bias, the result was not statistically significant (RR = 1.26, 95% CI = 0.94–1.68). Compared with NRT alone, only one RCT was included, and the effect of combination therapy on abstinence was not statistically significant (RR = 0.94, 95% CI = 0.51–1.72). AEs were more common with combination therapy compared with varenicline alone (RR = 1.11, 95% CI = 1.02–1.20). Specifically, skin reactions were significantly increased with NRT patch plus varenicline (RR = 1.67; 95% CI = 1.29–2.16). Compared with NRT alone, combination therapy was associated with increased AEs (RR = 1.23; 95% CI = 1.07–1.41). SAEs were infrequent and generally unrelated to treatment.
Conclusions
Low‐certainty evidence indicates that combining varenicline with nicotine replacement therapy may improve long‐term smoking cessation rates compared with varenicline alone and is generally well tolerated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of…
- China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- China-Japan Friendship School of Clinical Medicine, Capital Medical University, Beijing, China.
- School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Xinmei Zhou, Zhenxiao Huang, Qingqing Song, Xin Xia, Anqi Cheng, Zhao Liu, Min Wang, Tingfen Ji, Ailifeire Aihemaiti, Ying Xie, Yi Liu, Yingman Gao, Liang Zhao, Dan Xiao, Chen Wang
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine
Zitieren
APA
Zhou, X., Huang, Z., Song, Q., Xia, X., Cheng, A., Liu, Z., Wang, M., Ji, T., Aihemaiti, A., Xie, Y., Liu, Y., Shi, Y., Shi, S., Gao, Y., Liu, H., He, J., Zhao, L., Xiao, D., & Wang, C. (2026). Efficacy of combined varenicline and nicotine replacement therapy compared with varenicline or nicotine replacement therapy alone for smoking cessation: A systematic review and meta‐analysis. Addiction. https://doi.org/10.1111/add.70235
Vancouver
Zhou X, Huang Z, Song Q, Xia X, Cheng A, Liu Z, et al. Efficacy of combined varenicline and nicotine replacement therapy compared with varenicline or nicotine replacement therapy alone for smoking cessation: A systematic review and meta‐analysis. Addiction. 2026. doi:10.1111/add.70235
BibTeX
@article{Zhou2026,
author = {Zhou, Xinmei and Huang, Zhenxiao and Song, Qingqing and Xia, Xin and Cheng, Anqi and Liu, Zhao and Wang, Min and Ji, Tingfen and Aihemaiti, Ailifeire and Xie, Ying and Liu, Yi and Shi, Yuxin and Shi, Shunyi and Gao, Yingman and Liu, Hang and He, Jiahui and Zhao, Liang and Xiao, Dan and Wang, Chen},
title = {Efficacy of combined varenicline and nicotine replacement therapy compared with varenicline or nicotine replacement therapy alone for smoking cessation: A systematic review and meta‐analysis},
journal = {Addiction},
year = {2026},
doi = {10.1111/add.70235}
}
EUVIMED